Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_698
Snippet: Mirtazapine 2% transdermal ointment is effective in managing weight loss in cats. Use of 2% MZP resulted in a mean weight gain of 4.07% compared to 0.29% for placebo after two weeks of transdermal treatment. The product was generally well tolerated. Mirtazapine has been shown to increase body weight in cats. The purpose of this study was to evaluate single dose pharmacokinetics (PK) of mirtazapine in a novel formulation of mirtazapine 2% transder.....
Document: Mirtazapine 2% transdermal ointment is effective in managing weight loss in cats. Use of 2% MZP resulted in a mean weight gain of 4.07% compared to 0.29% for placebo after two weeks of transdermal treatment. The product was generally well tolerated. Mirtazapine has been shown to increase body weight in cats. The purpose of this study was to evaluate single dose pharmacokinetics (PK) of mirtazapine in a novel formulation of mirtazapine 2% transdermal ointment (2% MZP) in cats.
Search related documents:
Co phrase search for related documents- body weight and mean weight gain: 1, 2, 3, 4, 5, 6, 7, 8
- body weight and PK single dose pharmacokinetic: 1
- body weight and single dose pharmacokinetic: 1
- body weight and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- body weight and transdermal ointment: 1, 2
- body weight and weight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- body weight and weight loss: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78
- body weight increase and mean weight gain: 1, 2
- body weight increase and study purpose: 1, 2
- body weight increase and transdermal ointment: 1
- body weight increase and weight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- body weight increase and weight loss: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- dose pharmacokinetic and PK single dose pharmacokinetic: 1
- dose pharmacokinetic and single dose pharmacokinetic: 1, 2, 3, 4, 5, 6, 7
- dose pharmacokinetic and study purpose: 1, 2, 3
- dose pharmacokinetic and transdermal ointment: 1
- mean weight gain and study purpose: 1
- mean weight gain and weight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- mean weight gain and weight loss: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date